BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25411356)

  • 1. SRT1720 induces lysosomal-dependent cell death of breast cancer cells.
    Lahusen TJ; Deng CX
    Mol Cancer Ther; 2015 Jan; 14(1):183-92. PubMed ID: 25411356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice.
    Suzuki K; Hayashi R; Ichikawa T; Imanishi S; Yamada T; Inomata M; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Ogawa H; Sakurai H; Saiki I; Tobe K
    Oncol Rep; 2012 Jun; 27(6):1726-32. PubMed ID: 22470132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beneficial role of SIRT1 activator on chemo- and radiosensitization of breast cancer cells in response to IL-6.
    Masoumi H; Soltani A; Ghatrehsamani M
    Mol Biol Rep; 2020 Jan; 47(1):129-139. PubMed ID: 31781916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRT1720 induces SIRT1-independent cell death in adult T-cell leukemia/lymphoma.
    Kozako T; Kato N; Ohsugi T; Uchida YI; Yoshimitsu M; Ishitsuka K; Higaki Y; Sato H; Aikawa A; Honda SI
    FEBS J; 2022 Jun; 289(12):3477-3488. PubMed ID: 35029032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway.
    Chini CC; Espindola-Netto JM; Mondal G; Guerrico AM; Nin V; Escande C; Sola-Penna M; Zhang JS; Billadeau DD; Chini EN
    Clin Cancer Res; 2016 May; 22(10):2496-507. PubMed ID: 26655844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.
    Ichikawa T; Hayashi R; Suzuki K; Imanishi S; Kambara K; Okazawa S; Inomata M; Yamada T; Yamazaki Y; Koshimizu Y; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Sasahara M; Tobe K
    Respirology; 2013 Feb; 18(2):332-9. PubMed ID: 23062010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRT1720, a potential sensitizer for radiotherapy and cytotoxicity effects of NVB-BEZ235 in metastatic breast cancer cells.
    Fatehi D; Soltani A; Ghatrehsamani M
    Pathol Res Pract; 2018 Jun; 214(6):889-895. PubMed ID: 29653746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis.
    Tan P; Wang M; Zhong A; Wang Y; Du J; Wang J; Qi L; Bi Z; Zhang P; Lin T; Zhang J; Yang L; Chen J; Han P; Gong Q; Liu Y; Chen C; Wei Q
    Oncogene; 2021 Oct; 40(42):6081-6092. PubMed ID: 34471236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress.
    Ren Y; Du C; Shi Y; Wei J; Wu H; Cui H
    Int J Mol Med; 2017 May; 39(5):1317-1324. PubMed ID: 28339034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of SRT1720 on the apoptosis of rabbit chondrocytes by activating SIRT1 via p53/bax and NF-κB/PGC-1α pathways.
    Liu B; Lei M; Hu T; Yu F; Xiao DM; Kang H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):350-355. PubMed ID: 27376802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
    Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells.
    Chauhan D; Bandi M; Singh AV; Ray A; Raje N; Richardson P; Anderson KC
    Br J Haematol; 2011 Dec; 155(5):588-98. PubMed ID: 21950728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Sirt1 Activator-mediated Improvement in Glucose Homeostasis Requires Sirt1-Independent Activation of AMPK.
    Park SJ; Ahmad F; Um JH; Brown AL; Xu X; Kang H; Ke H; Feng X; Ryall J; Philp A; Schenk S; Kim MK; Sartorelli V; Chung JH
    EBioMedicine; 2017 Apr; 18():128-138. PubMed ID: 28396013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
    Sonnemann J; Kahl M; Siranjeevi PM; Blumrich A; Blümel L; Becker S; Wittig S; Winkler R; Krämer OH; Beck JF
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):17-26. PubMed ID: 26055805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Agonist of the Protective Factor SIRT1 Improves Functional Recovery and Promotes Neuronal Survival by Attenuating Inflammation after Spinal Cord Injury.
    Chen H; Ji H; Zhang M; Liu Z; Lao L; Deng C; Chen J; Zhong G
    J Neurosci; 2017 Mar; 37(11):2916-2930. PubMed ID: 28193684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts.
    Kim TH; Kim HS; Kang YJ; Yoon S; Lee J; Choi WS; Jung JH; Kim HS
    Biochim Biophys Acta; 2015 Feb; 1850(2):401-10. PubMed ID: 25445714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 activation by SRT1720 attenuates bone cancer pain via preventing Drp1-mediated mitochondrial fission.
    Li MY; Ding JQ; Tang Q; Hao MM; Wang BH; Wu J; Yu LZ; Jiao M; Luo BH; Xie M; Zhu HL
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):587-598. PubMed ID: 30579931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of structurally diverse BET inhibitors on SIRT1.
    Tenhunen J; Kokkola T; Huovinen M; Rahnasto-Rilla M; Lahtela-Kakkonen M
    Gene; 2020 May; 741():144558. PubMed ID: 32165310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.